Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 373 entries
View as:

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01983540 Org: User:
Start: 10/31/13 End: 12/31/15 Due: 12/31/16

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00862277 Org: User:
Start: 12/31/08 End: 12/31/09 Due: 12/31/10

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Phase: N/A Priority: Normal
NCT ID: NCT04398706 Org: User:
Start: 05/22/20 End: 08/10/23 Due: 08/10/24

Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00457509 Org: User:
Start: 01/31/07 End: 09/30/10 Due: 09/30/11

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Phase: N/A Priority: Normal
NCT ID: NCT00755274 Org: User:
Start: 09/30/08 End: 01/31/09 Due: 01/31/10

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

Phase: N/A Priority: Normal
NCT ID: NCT00735644 Org: User:
Start: 08/31/08 End: 08/31/09 Due: 08/31/10

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively

Phase: N/A Priority: Normal
NCT ID: NCT04109222 Org: User:
Start: 09/30/19 End: 12/10/19 Due: 12/10/20

Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00545701 Org: User:
Start: 10/31/07 End: 09/30/08 Due: 09/30/09

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04537234 Org: User:
Start: 11/10/20 End: 02/09/21 Due: 02/09/22

Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00389532 Org: User:
Start: 10/31/06 End: 09/30/08 Due: 09/30/09

Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00776438 Org: User:
Start: 09/30/07 End: 04/30/09 Due: 04/30/10

Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01389687 Org: User:
Start: 07/31/11 End: 01/31/12 Due: 01/31/13

Postmarketing Surveillance Study for IMOJEV® in Republic of Korea

Phase: N/A Priority: Normal
NCT ID: NCT02933710 Org: User:
Start: 07/21/16 End: 10/18/18 Due: 10/18/19

Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00772109 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children

Phase: N/A Priority: Normal
NCT ID: NCT01477671 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT03890367 Org: User:
Start: 09/12/19 End: 10/14/20 Due: 10/14/21

Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02591290 Org: User:
Start: 10/20/15 End: 03/16/16 Due: 03/16/17

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00442169 Org: User:
Start: 12/31/05 End: 04/30/09 Due: 04/30/10

Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Phase: N/A Priority: Normal
NCT ID: NCT00601835 Org: User:
Start: 05/31/04 End: 07/31/05 Due: 07/31/06

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT01249183 Org: User:
Start: 10/31/10 End: 09/30/11 Due: 09/30/12

Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

Phase: N/A Priority: Normal
NCT ID: NCT00604058 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00304265 Org: User:
Start: 03/31/06 End: 10/31/07 Due: 10/31/08

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Phase: N/A Priority: Normal
NCT ID: NCT00269477 Org: User:
Start: 12/31/05 End: 12/31/07 Due: 12/31/08

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00643916 Org: User:
Start: 12/31/04 End: 10/31/07 Due: 10/31/08

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06641180 Org: User:
Start: 11/04/24 End: 06/24/25 Due: 06/24/26